Ajanta Pharma Overview

  • Year Founded
  • 1973

Year Founded

  • Status
  • Public

  • Employees
  • 12,237

Employees

  • Stock Symbol
  • 532331

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $29.81
  • (As of Friday Closing)

Ajanta Pharma General Information

Description

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a presence while generating the vast majority of its revenue in India. The company aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, creams, injectables, capsules, liquids, and lotion. The company's manufacturing plants are located in India.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Ajanta House, Charkop
  • Kandivli West
  • Mumbai, Maharashtra 400067
  • India
+91 022
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • Ajanta House, Charkop
  • Kandivli West
  • Mumbai, Maharashtra 400067
  • India
+91 022

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ajanta Pharma Stock Performance

As of 20-Jun-2025, Ajanta Pharma’s stock price is $29.81. Its current market cap is $3.72B with 125M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$29.81 $29.37 $23.64 - $41.50 $3.72B 125M 3.22K $0.87

Ajanta Pharma Financials Summary

As of 31-Mar-2025, Ajanta Pharma has a trailing 12-month revenue of $543M.

In Thousands,
USD
TTM 31-Mar-2025 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023
EV 3,737,202 3,737,202 3,325,379 1,814,337
Revenue 542,555 542,555 502,693 461,721
EBITDA 154,557 154,557 148,435 108,775
Net Income 108,853 108,853 98,588 73,225
Total Assets 586,274 586,274 556,205 569,910
Total Debt 5,544 5,544 4,231 4,340
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ajanta Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ajanta Pharma‘s full profile, request access.

Request a free trial

Ajanta Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintai
Pharmaceuticals
Mumbai, India
12,237 As of 2025

Ahmedabad, India
 

Hyderabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ajanta Pharma Competitors (39)

One of Ajanta Pharma’s 39 competitors is Torrent Pharmaceuticals, a Corporation company based in Ahmedabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Torrent Pharmaceuticals Corporation Ahmedabad, India
Granules India Corporation Hyderabad, India
Glenmark Pharmaceuticals Corporation Mumbai, India
Jubilant Pharmova Corporation Noida, India
Mankind Pharma Formerly PE-Backed New Delhi, India
You’re viewing 5 of 39 competitors. Get the full list »

Ajanta Pharma Patents

Ajanta Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100179202-A1 Orally disintegrating composition of zolmitriptan Inactive 14-Jan-2009
US-20020012702-A1 Oral formulation comprising 45-65% by weight nimesulide and 10-30% by weight hydrophilic polymer as retardant Inactive 20-Jun-2000
EP-1406635-A2 A controlled release anti-inflammatory formulation and a process for the preparation thereof Inactive 20-Jun-2000
AU-2001284382-A1 A controlled release anti-inflammatory formulation and a process for the preparation thereof Inactive 20-Jun-2000
AU-4429000-A Nutrients rich low fat high fiber carrot product Inactive 29-Jan-1999 A61K36/23
To view Ajanta Pharma’s complete patent history, request access »

Ajanta Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ajanta Pharma Acquisitions (1)

Ajanta Pharma’s most recent deal was a Merger/Acquisition with CAPS Pharmaceuticals. The deal was made on 05-Apr-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CAPS Pharmaceuticals 05-Apr-2018 Merger/Acquisition Pharmaceuticals
To view Ajanta Pharma’s complete acquisitions history, request access »

Ajanta Pharma ESG

Risk Overview

Risk Rating

Updated October, 15, 2024

30.74 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,673

Rank

Percentile

Pharmaceuticals

Industry

of 844

Rank

Percentile

Pharmaceuticals

Subindustry

of 419

Rank

Percentile

To view Ajanta Pharma’s complete esg history, request access »

Ajanta Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
CAPS Pharmaceuticals Harare, Zimbabwe 1952

Ajanta Pharma FAQs

  • When was Ajanta Pharma founded?

    Ajanta Pharma was founded in 1973.

  • Where is Ajanta Pharma headquartered?

    Ajanta Pharma is headquartered in Mumbai, India.

  • What is the size of Ajanta Pharma?

    Ajanta Pharma has 12,237 total employees.

  • What industry is Ajanta Pharma in?

    Ajanta Pharma’s primary industry is Pharmaceuticals.

  • Is Ajanta Pharma a private or public company?

    Ajanta Pharma is a Public company.

  • What is Ajanta Pharma’s stock symbol?

    The ticker symbol for Ajanta Pharma is 532331.

  • What is the current stock price of Ajanta Pharma?

    As of 20-Jun-2025 the stock price of Ajanta Pharma is $29.81.

  • What is the current market cap of Ajanta Pharma?

    The current market capitalization of Ajanta Pharma is $3.72B.

  • What is Ajanta Pharma’s current revenue?

    The trailing twelve month revenue for Ajanta Pharma is $543M.

  • Who are Ajanta Pharma’s competitors?

    Torrent Pharmaceuticals, Granules India, Glenmark Pharmaceuticals, Jubilant Pharmova, and Mankind Pharma are some of the 39 competitors of Ajanta Pharma.

  • What is Ajanta Pharma’s annual earnings per share (EPS)?

    Ajanta Pharma’s EPS for 12 months was $0.87.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »